Case Page

 

Case Status:    DISMISSED    
On or around 08/12/2015 (Other)

Filing Date: January 27, 2014

According to the law firm press release, it is alleged that Sarepta issued a series of multiple statements concerning, among other things: (1) the prospects of the Food and Drug Administration's ("FDA") acceptance for consideration of a New Drug Application ("NDA") for eteplirsen based on Sarepta's Phase IIb study data set, and (2) the significance of that data set. However, during a meeting on November 12, 2013, the FDA informed Sarepta that its announced, anticipated NDA filing for eteplirsen was premature. On this negative news, Sarepta's stock price fell $23.40, a decline of 64%, from its closing price of $36.56 per share on November 11, 2013, to $13.16 per share on November 12, 2013, on extraordinary volume.

On June 23, 2014, the Court issued an Order appointing lead plaintiff and approving the selection of lead counsel. Lead Plaintiffs filed an amended complaint on July 21.

On March 31, 2015, the Court issued an Order granting Defendants' Motion to Dismiss.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: SRPT
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Massachusetts
DOCKET #: 14-CV-10201
JUDGE: Hon. Marianne B. Bowler
DATE FILED: 01/27/2014
CLASS PERIOD START: 07/24/2013
CLASS PERIOD END: 11/12/2013
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Federman & Sherwood (Oklahoma City)
    10205 N. Pennsylvania, Federman & Sherwood (Oklahoma City), OK 73120
    405.235.1560 405.235.1560 ·
  2. Law Office Of Alan L. Kovacs
    2001 Beacon St., Suite 106, Law Office Of Alan L. Kovacs, MA 02135
    617.964.1177 617.964.1177 ·
No Document Title Filing Date
COURT: D. Massachusetts
DOCKET #: 14-CV-10201
JUDGE: Hon. Marianne B. Bowler
DATE FILED: 07/21/2014
CLASS PERIOD START: 07/10/2013
CLASS PERIOD END: 11/11/2013
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Federman & Sherwood (Oklahoma City)
    10205 N. Pennsylvania, Federman & Sherwood (Oklahoma City), OK 73120
    405.235.1560 405.235.1560 ·
  2. Law Office Of Alan L. Kovacs
    2001 Beacon St., Suite 106, Law Office Of Alan L. Kovacs, MA 02135
    617.964.1177 617.964.1177 ·
  3. Wolf Haldenstein Adler Freeman & Herz LLP (New York)
    270 Madison Avenue, Wolf Haldenstein Adler Freeman & Herz LLP (New York), NY 10016
    212.545.4600 212.686.0114 · newyork@whafh.com
No Document Title Filing Date